New York A 3236: Enacts the "New York affordable drug manufacturing act"

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A03236 Summary:

BILL NOA03236 

&nbsp

SAME ASSAME AS S01618

&nbsp

SPONSORRajkumar

&nbsp

COSPNSRRosenthal, Seawright, Colton, Santabarbara, Simon, Griffin, Forrest, Steck, Dinowitz, Stern,
 Gonzalez-Rojas

&nbsp

MLTSPNSR

&nbsp

Add Art 2-A Title IV §§282 - 285, Pub Health L

&nbsp

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Go to top A03236 Actions:

BILL NOA03236 

&nbsp

01/27/2025referred to health

01/07/2026referred to health

Go to topA03236 Committee&nbspVotes:

Go to topA03236 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA03236 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 3236

 2025-2026 Regular Sessions

 IN ASSEMBLY

 January 27, 2025
 ___________

 Introduced by M. of A. RAJKUMAR, ROSENTHAL, SEAWRIGHT -- read once and
 referred to the Committee on Health

 AN ACT to amend the public health law, in relation to enacting the "New
 York affordable drug manufacturing act"

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Short title. This act shall be known and may be cited as
 2 the "New York affordable drug manufacturing act".
 3 § 2. Article 2-A of the public health law is amended by adding a new
 4 title IV to read as follows:
 5 TITLE IV
 6 NEW YORK AFFORDABLE DRUG MANUFACTURING ACT
 7 Section 282. Definitions.
 8 283. Partnerships; production and distribution of generic
 9 prescription drugs.
 10 284. Reporting.
 11 285. Proprietary information.
 12 § 282. Definitions. As used in this title, the following terms shall
 13 have the following meanings:
 14 1. "Generic prescription drug" means a drug that is approved pursuant
 15 to an application submitted under subdivision (j) of section 355 of the
 16 Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 301 et seq.), or a
 17 biosimilar, as defined under the federal Public Health Service Act (42
 18 U.S.C. Sec. 262) that is not under patent.
 19 2. "Partnerships" means agreements for the procurement of generic
 20 prescription drugs by way of contracts or purchasing by a payer, state
 21 governmental agency, group purchasing organization, nonprofit organiza-
 22 tion, or other entity.
 23 § 283. Partnerships; production and distribution of generic
 24 prescription drugs. 1. (a) The commissioner shall enter into partner-
 25 ships, consistent with paragraph (b) of subdivision two of this section,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD04133-01-5

 A. 3236 2

 1 in consultation with all appropriate state agencies and the department
 2 of health or equivalent institution of any other state as determined by
 3 the commissioner, to increase competition, lower prices, and address
 4 shortages in the market for generic prescription drugs, to reduce the
 5 cost of prescription drugs for public and private purchasers, taxpayers,
 6 and consumers, and to increase patient access to affordable drugs.
 7 (b) The department shall have the ability to hire staff to oversee and
 8 project-manage the partnerships for manufacturing or distribution of
 9 generic prescription drugs.
 10 2. (a) The commissioner shall enter into partnerships resulting in the
 11 production or distribution of generic prescription drugs, with the
 12 intent that these drugs be made widely available to public and private
 13 purchasers, facilities licensed pursuant to article twenty-eight of this
 14 chapter, and pharmacies as defined in section six thousand eight hundred
 15 two of the education law, as appropriate. The generic prescription drugs
 16 shall be produced or distributed by a drug company or generic drug
 17 manufacturer that is registered with the United States Food and Drug
 18 Administration.
 19 (b) (i) The commissioner shall only enter into partnerships pursuant
 20 to paragraph (a) of this subdivision to produce a generic prescription
 21 dru